Mechanisms mediating the immune response after proton versus photon radiotherapy in IDH-mutant liver cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110738
- Recipient
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $826,584
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02114, USA
Award details come from USAspending.gov.
About this award
The Massachusetts General Hospital will receive $826,584 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into the mechanisms mediating the immune response after proton versus photon radiotherapy in IDH-mutant liver cancer. The study aims to investigate medical solutions for the battlefield and transform health care for service members and the public through innovative biomedical research. The award period runs from September 1, 2021 through August 31, 2024 and performance will take place in Boston.
Quick answers
Who received award W81XWH2110738?
W81XWH2110738 was awarded to The General Hospital Corporation by Medical Command (Department of the Army) on September 1, 2021.
How much is award W81XWH2110738 worth?
$826,584 has been obligated on W81XWH2110738.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award